Medical Weight Loss for Lynn, Massachusetts Residents

Lynn, Massachusetts residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Lynn through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Lynn: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps Massachusetts patients choose. Doctor review just $119 (medication separate).

Why Lynn Residents Choose New Hope Weight Loss

We made New Hope easy to start without making it less serious. A Lynn patient can go from first visit to a physician-approved plan without insurance paperwork, prior authorizations, or a single drive to an office. The $119 review with Dr. Anjmun Sharma is flat, the medication price is published, and the whole thing happens by telehealth. Low friction to begin, real medicine once you do, the same standard everyone in Massachusetts gets.

Lynn is part of the area New Hope Weight Loss serves by telehealth. The same compounded semaglutide and tirzepatide protocols, the same flat pricing, and the same bilingual support reach Lynn patients at home.

Whether you are near downtown Lynn or somewhere quieter in Massachusetts, the same doctor-supervised plan runs over telehealth, with our only physical location remaining in Costa Mesa, California. We care for patients throughout Downtown and the greater North Shore area of metro Boston, with bilingual Spanish care. Compounded semaglutide and tirzepatide are not FDA-approved and not brand-identical, and Dr. Sharma will walk you through what that means for you in plain terms.

By handling visits through telehealth, we serve every neighborhood in Lynn, from Downtown and the greater North Shore area of metro Boston, with bilingual Spanish care, without asking anyone to travel. Patients anywhere in Massachusetts, including the Downtown and the greater North Shore area of metro Boston, with bilingual Spanish care neighborhoods, get the same pricing because care is delivered by telehealth from our Costa Mesa clinic. Across the densely populated communities of Massachusetts, New Hope Weight Loss cares for patients by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Which GLP-1 program is right for you?

Our 90-Day Metabolic Reset runs on semaglutide, the same active ingredient as Wegovy and Ozempic. It starts at $166 a month, or $499 for 90 days, and branded-drug trials reported average loss near 15 to 17 percent. Because compounded semaglutide is not FDA-approved or brand-identical, results vary. Dr. Sharma guides every Lynn patient by telehealth.

And if you want more horsepower

Tirzepatide, from $233 a month, adds GIP to the usual GLP-1 action. In branded-drug trials, dose-qualified participants reached up to 22.5 percent loss, which is not the typical outcome. It shares its active ingredient with Mounjaro and Zepbound.

A $119 physician review starts the process. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Lynn

Starting care with us looks nothing like a traditional doctor visit. There is no office to find and no drive across Lynn. You complete an online intake quiz covering your health background and weight goals, and Dr. Anjmun Sharma reviews it personally. She then meets you by secure video, typically within 48 hours, to decide together whether compounded semaglutide or tirzepatide is appropriate. If it is, a state-licensed 503(a) pharmacy ships your medication to your Lynn address in cold-pack packaging that protects it in transit, and all of your follow-ups happen by video so your plan keeps moving wherever you are in .

Frequently Asked Questions, Lynn

Does New Hope Weight Loss have a presence in Lynn?

Our presence in Lynn is through telehealth rather than a storefront. The clinic itself is in Costa Mesa, California, our sole physical location. We serve Lynn, Massachusetts patients online, and Dr. Anjmun Sharma confirms your eligibility for compounded semaglutide or tirzepatide during a private video consultation.

Could a Lynn patient complete care without leaving home?

Yes, staying home is the norm. Everything for Lynn patients runs over telehealth, including the initial consult, dose adjustments, and check-ins. After approval, your medication travels to Lynn in insulated cold-pack shipping that protects it from temperature swings during delivery.

How are Lynn patients charged?

There is a $119 fee for the physician review. Semaglutide starts at $166 monthly, with a 90-day option at $499, and tirzepatide at $233 monthly. The medication itself is a separate cost. We accept HSA, FSA, Klarna, and Affirm, and we add no distance surcharge for Lynn.

What areas of Lynn do you serve?

We serve patients from across Lynn by telehealth, including Downtown and the greater North Shore area of metro Boston, with bilingual Spanish care.

How does compounded medication compare on cost for Lynn patients?

Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Lynn patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.

Lynn Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Lynn, Massachusetts by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.